Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Mirum Pharmaceuticals has appointed Eric Bjerkholt as Chief Financial Officer. Bjerkholt comes to Mirum from Chinook Therapeutics, where he served as CFO overseeing financial reporting, planning and budgeting, internal controls, investor relations, facilities, and information technology functions.
read more
Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma for the development, manufacturing and commercialization of the orally administered Janus kinase (JAK) inhibitor Smyraf® 50 mg and 100 mg tablets (generic name: peficitinib hydrobromide) in Taiwan for the treatment of rheumatoid arthritis.
read more
Johnson & Johnson updated its brand and uniting both its medtech and pharmaceutical segments under the Johnson & Johnson brand name to demonstrate its collective power in healthcare.
read more
Based on new data, FDA has concerns about whether the tacrolimus oral capsule products manufactured by Accord Healthcare Inc., are therapeutically equivalent to the brand-name drug, Prograf (tacrolimus) oral capsules.
read more
The Syntegon Group, a provider of processing and packaging technology, appointed Torsten Türling as new Chief Executive Officer (CEO).
read more
Bora Health, a global design, development and distribution partner of pharmaceuticals and health foods and part of the Bora group, has announced its collaboration with Sunway Biotech, a leading ingredients manufacturer, and research and development (R&D) organization.
read more
Mikart announced its recent acquisition of the state-of-the-art Flexpack NF-150 Horizontal Sachet-Packaging Machine.
read more
Senores Pharmaceuticals announced the launch of Nicardipine Hydrochloride Capsules USP, 20 mg and 30 mg, a bioequivalent and therapeutically equivalent to Cardene Capsules, 20 mg and 30 mg, of Chiesi USA in the US market.
read more
The global rice bran derivatives market is on a trajectory to reach a market size of USD 10.1 billion by 2030, with a strong CAGR of 5.6% from 2023 to 2030.
read more
SCYNEXIS, Inc. is conducting a voluntary nationwide recall of 2 lots of BREXAFEMME® (ibrexafungerp tablets) to the consumer level in the US market due to potential cross contamination with a non-antibacterial ß-lactam drug substance in the ibrexafungerp citrate used to manufacture the BREXAFEMME® tablets.
read more
Fabre-Kramer Pharmaceuticals announced that the FDA approved Exxua™ (gepirone hydrochloride extended-release tablets) for the treatment of major depressive disorder (MDD) in adults.
read more
Vitaquest International, an industry-leading product development and commercialization partner in nutraceuticals and functional foods, has acquired the Paterson, New Jersey-based powder processing facility from Pharmachem Laboratories, a division of Ashland Inc.
read more
Novella, Ltd. Has unveiled prototypes of its new line of berry-derived bioactives. The company is in the advanced stages of developing intact-cell berry compounds grown outside of the plant using novel, precision-controlled-environment technology.
read more
AstraZeneca's supplemental New Drug Application (sNDA) for TAGRISSO® (osimertinib) in conjunction with chemotherapy received acceptance and been granted Priority Review in the US for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC).
read more
Bristol Myers Squibb released new three-year results from the POETYK PSO long-term extension (LTE) trial evaluating Sotyktu (deucravacitinib) treatment in adult patients with moderate-to-severe plaque psoriasis.
read more